Atopic Dermatitis Research Study (27 Weeks)

Males and females aged 18-75 with a documented history of chronic atopic dermatitis (AD) for at least 1 year, may qualify to participate. A body mass index between 19 and 40 kg/m2 inclusive, is required. Individuals must have moderate to severe disease severity, with AD that affects ≥ 10% of the body surface area.

A documented history (within the past 6 months) of inadequate response to topical medications for AD, intolerance to treatment with topical medications for AD, or for whom topical medications are otherwise medically inadvisable, is also required.

Participants will receive investigational medication (active study drug) or placebo, via injection. Study medication and study-related care will be provided at no cost. Reimbursement for study-related expenses will also be provided.

Study participation will last about 27 weeks and involve about 12 visits to the study centre.

Call the study centre near you, or register now

Learn more about
Atopic Dermatitis
Register Now!

Participating Locations

AR

  • Sorry no locations are available in this country.

CA

  • Sorry no locations are available in this country.

CL

  • Sorry no locations are available in this country.

MX

  • Sorry no locations are available in this country.

US

  • Sorry no locations are available in this country.

Register for
Active Studies!

Register

All information about you will be kept confidential.

If there are no active studies for your condition, we will keep your information and contact you when a new study starts in your area.

By registering you are consenting to the terms and conditions of our privacy policy.

Find the clinic near you:

Why Take Part In a Clinical Study?

Regulatory agencies like Health Canada, Australia's Therapeutic Goods Administration and the FDA require that Clinical Research Trials be conducted in order to develop new treatments, preventions and devices for diseases or conditions. Clinical Research Trials are also referred to as Clinical Studies or Clinical Trials. read more